ORKA

Oruka Therapeutics, Inc. Common Stock
ORKA

Overview Fund Activity

24 hedge funds and large institutions have $4.17M invested in Oruka Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
3
Closed
5
Calls
$328K
Puts
$3.96M
Net Calls
-$3.63M
Net Calls Change
-$3.71M

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$568K
2
Group One Trading
2
Group One Trading
Illinois
$327K
3
M
3
Murchinson
Ontario, Canada
$126K
4
Millennium Management
4
Millennium Management
New York
$148K
5
B
5
Bailard
California
$87K

Top Sellers

1
VF
1
Virtu Financial
New York
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$110K
3
BlackRock
3
BlackRock
New York
$658K
4
TRCT
4
Tower Research Capital (TRC)
New York
$0
5
Simplex Trading
5
Simplex Trading
Illinois
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
– -$2K -56 Closed
1
2